Withaferin-A: A Potential Anticancer Withanolide from Withania somnifera (L.) Dun.
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Withania somnifera (Ashwagandha) is a plant used in medicine from the time of Ayurveda, the ancient system of Indian medicine. The dried roots
of the plant are used in the treatment of nervous and sexual disorders. From chemistry point of view, the drug contains group of biologically active
constituents known as withanolides. The chemical structures of withanolides have been studied and they are widely distributed in family Solanacae.
Withaferin- A is therapeutically active withanolide reported to be present in leaves. In animal studies, withaferin-A has shown significant
anticancer activity. Majority of the anticancer drugs like Vinblastine, Vincristine, and Taxol have been derived from green flora. Today there is
much interest in natural products with anticancer activity. Withanolides are of under research potential as far treatment of cancer is concerned. The
article reviews the scope of studies published in favor of anticancer potential of withaferin-A.
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Introduction and chemistry
Withanolides are group of pharmacologically active compounds present in roots and leaves of Withania somnifera. The
extract of the plant available in the market is standardised to withanolide content. . The chemistry of withanolides has
been studied and they are basically steroidal lactones (highly oxygenated C-28 steroid derivatives). Withanolides are
similar to ginsenosides (the active constituents of Panax ginseng) in structure and activity. They are believed to be
immunomodulator, which most probably accounts for anticancer activity.
Withaferin-A has been assigned following structure: -

Anticancer studies
1.Withaferin- A, isolated from the roots of Withania somnifera, reduced survival of V79 cells in a dose-dependent
manner. LD50 for survival was 16 microM. One-hour treatment with a non-toxic dose of 2.1 microM before irradiation
significantly enhanced cell killing, giving a sensitizer enhancement ratio (SER) of 1.5 for 37% survival and 1.4 for
10% survival. SER increased with drug dose, but at higher doses the increased lethality appears to be due to two
effects-- drug toxicity and radiosensitization. The drug induced a G2/M block, with a maximum accumulation of cells
in G2-M phase at 4 h after treatment with 10.5 microM withaferin A in 1 h.

2.Withaferin- A showed marked tumour-inhibitory activity when tested in vitro against cells derived from human
carcinoma of nasopharynx (KB). It also acted as a mitotic poison arresting the division of cultured human larynx
carcinoma cells at metaphase and in HeLa cultures similar to star -metaphase. It also produced significant retardation
of the growth of Ehrlich ascites carcinoma, Sarcoma 180, Sarcoma Black (SBL), and E 0771 mammary
adenocarcinoma in mice in doses of 10, 12, 15 mg./kg. body-wt. Growth of Ehrlich ascites carcinoma was completely
inhibited in more than half the mice, which survived for 100 days without the evidence of growth of the tumour.
Withaferin A caused mitotic arrest in embryonal chicken fibroblast cells.
3.The alcoholic extract of the dried roots of the plant as well as the active component withaferin- A isolated from the
extract showed significant antitumor and radiosensitizing effects in experimental tumors in vivo, without any
noticeable systemic toxicity. Withaferin A gave a sensitizer enhancement ratio of 1.5 for in vitro cell killing of V79
Chinese hamster cells at a non-toxic concentration of approximately 2 microM. The mechanism of action of this
compound is not known.
Conclusion: The studies so far indicate that W. somnifera could prove to be a good natural source of a potent and
relatively safe radiosensitizer/chemotherapeutic agent.
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